Patient-Reported Health-Related Quality of Life from the Phase Iii Tourmaline-Mm1 Study of Ixazomib-Lenalidomide-Dexamethasone Versus Placebo-Lenalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma
AuthID
P-00P-GKM
P-00P-GKM